At5g39180 is a germin-like protein in Arabidopsis thaliana that functions as a secreted Mn-binding protein with an important role in plant defense mechanisms. This protein belongs to the RmlC-like cupins superfamily and has been identified as differentially regulated in various stress and defense-related experimental conditions .
According to transcriptomic analyses, At5g39180 is among the genes down-regulated in BAK1 (Y610F)-Flag plants compared to wild-type BAK1, with a fold change of 0.88 (log2) or 1.84 (FC) as shown in the following data:
| Gene locus ID | Gene description | BAK1/Y610F |
|---|---|---|
| AT5G39180* | RmlC-like cupins superfamily protein | 0.88 |
*The asterisk identifies this gene as selected for qPCR analysis in studies examining BAK1 function in plant immunity .
Methodologically, researchers interested in At5g39180 often study its expression patterns in response to immune elicitors like flg22 or elf18, as well as its potential role in PAMP-triggered immunity (PTI) signaling cascades.
Validating antibody specificity for At5g39180 requires a multi-step approach following established antibody validation protocols:
Expected localization testing: Confirm that the antibody produces staining patterns consistent with the expected subcellular localization of At5g39180 (secreted protein).
Quantitative titration: Determine optimal antibody concentration through serial dilutions, typically starting at 1:1000 for Western blots based on similar germin-like protein antibodies .
Orthogonal validation: Compare protein detection using alternative methods such as:
Mass spectrometry validation of immunoprecipitated proteins
Correlation with mRNA expression levels through RT-PCR
Using epitope-tagged recombinant At5g39180 as a positive control
Genetic validation: Test the antibody in:
Knockout/knockdown lines of At5g39180
Overexpression lines
CRISPR-edited lines with targeted mutations
As noted in comprehensive antibody validation protocols, researchers should document "common pitfalls" such as nonspecific staining patterns due to suboptimal antibody concentration, which may lead to false interpretations of expression patterns .
For optimal extraction of At5g39180 protein from Arabidopsis tissues, the following protocol is recommended based on successful extraction of similar germin-like proteins:
Materials:
Liquid nitrogen
Mortar and pestle
Protein extraction buffer: 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 250 mM mannitol, 5 mM EDTA, 10% glycerol, 0.5% (w/v) polyvinylpolypyrollidone, protease inhibitors
Acid-washed sand
Miracloth (Calbiochem)
Ultracentrifuge
Procedure:
Collect plant tissue (10-day-old seedlings grown under long day conditions work well for germin-like proteins)
Grind tissue to a powder in liquid nitrogen
Homogenize frozen powdered tissue with twice the volume of protein extraction buffer plus acid-washed sand
Filter through Miracloth
Centrifuge at 15,000 g for 30 min to remove debris
For membrane-associated fractions, ultracentrifuge the supernatant at 100,000 g for 60 min at 4°C
Resuspend the pellet in extraction buffer containing 1% Triton X-100
This protocol has been validated for extraction of proteins that interact with BAK1, including potential downstream targets like At5g39180, and ensures preservation of protein activity and native conformation.
For immunoprecipitation (IP) studies to identify At5g39180 interaction partners, implement the following specialized protocol:
Materials:
Anti-At5g39180 antibody
Protein A/G magnetic beads
Modified extraction buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol, 1% IGEPAL CA630, 1× protease inhibitor cocktail, phosphatase inhibitors (2.5 mM Na₃VO₄, 100 nM calyculin A)
Western blot equipment
Procedure:
Extract proteins from treated and control plant tissues using the modified extraction buffer (2 mL per gram of tissue)
Normalize protein concentrations to 1-2 mg/mL using Bradford assay
Pre-clear lysates with bare beads for 1 hour at 4°C
Incubate cleared lysates with 2-5 μg of At5g39180 antibody overnight at 4°C
Add protein A/G beads and incubate for 2-3 hours at 4°C
Wash beads 3-5 times with binding buffer containing 50 mM Tris-HCl (pH 7.5) and 250 mM NaCl
Elute proteins with 2× SDS-PAGE sample buffer
Analyze by SDS-PAGE followed by either:
For validation, perform reciprocal co-immunoprecipitation and include appropriate controls such as IgG control and At5g39180 knockout lines to confirm specificity of the interactions.
At5g39180 expression dynamics during immune responses can be comprehensively monitored using a multi-technique approach:
qRT-PCR analysis:
Implement a time-course experiment following pathogen or PAMP treatment:
Treat plants with immune elicitors (e.g., flg22, elf18) or pathogens
Collect samples at multiple timepoints (0, 4, 8, 12, 16, 20, 24, 48 hours)
Extract RNA using TRIzol or similar reagent
Synthesize cDNA and perform qRT-PCR with At5g39180-specific primers
Normalize expression to reference genes (e.g., UBQ5 or β-tubulin)
Protein level detection:
Perform Western blot analysis using validated At5g39180 antibody
Compare protein abundance across treatment timepoints
Quantify band intensity using image analysis software
Research data indicates that At5g39180, as a germin-like protein, is likely to show expression patterns similar to other defense-related genes that are differentially regulated during pathogen-associated molecular pattern (PAMP)-triggered immunity. In BAK1 signaling studies, At5g39180 was down-regulated in BAK1(Y610F) mutant plants, suggesting it may be positively regulated by wild-type BAK1-mediated immunity pathways .
Producing specific antibodies against At5g39180 presents several technical challenges due to the conserved nature of germin-like proteins:
Epitope selection challenges:
Germin-like proteins share highly conserved germin domains
At5g39180 shares sequence homology with other members of the RmlC-like cupins superfamily
Selection of unique epitopes requires careful bioinformatic analysis to identify regions specific to At5g39180
A strategic approach involves:
Performing multiple sequence alignment of all Arabidopsis germin-like proteins
Identifying unique regions with at least 8-10 amino acid differences
Selecting epitopes from surface-exposed regions while avoiding glycosylation sites
Using immunoinformatic tools to predict epitope antigenicity and accessibility
Cross-reactivity testing requirements:
Testing must include validation against multiple related proteins. For example, cross-reactivity should be assessed against other germin-like proteins in Arabidopsis, including those encoded by At5g39150 and At5g39120, which are closely related paralogs .
Expression strategy considerations:
Recombinant protein expression for antibody production may require:
Expression of the full-length protein for polyclonal antibody generation
Expression of unique epitopes fused to carrier proteins for monoclonal antibody production
Careful refolding protocols if the protein forms inclusion bodies in E. coli
Consideration of plant-based expression systems to ensure proper post-translational modifications
Utilizing At5g39180 antibodies in protein microarray studies requires specialized methodologies:
Production of Arabidopsis protein microarrays:
Clone At5g39180 cDNA along with other Arabidopsis proteins into Gateway-compatible E. coli expression vectors
Express and purify RGS-His6-tagged recombinant proteins in high throughput
Robotically array proteins onto glass slides coated with:
Applications in immunity research:
Antibody specificity profiling:
Spot At5g39180 along with other germin-like proteins and control proteins
Probe with anti-At5g39180 antibody to assess cross-reactivity
Protein-protein interaction studies:
Probe arrays with fluorescently labeled interacting proteins
Detect interaction partners using fluorescence scanning
Plant immunity pathway mapping:
Create arrays containing proteins from immunity pathways
Probe with At5g39180 to identify direct interactions
Analyze using control antibodies (e.g., anti-RGS-His6) for normalization
As demonstrated in published microarray studies, this approach can successfully detect specific antibody-antigen interactions without cross-reactivity to other spotted proteins, even those from related protein families, making it valuable for confirming antibody specificity .
For optimal immunolocalization of At5g39180 in plant tissues, implement the following specialized protocol:
Materials:
Validated At5g39180-specific antibody
Fixative: 4% paraformaldehyde in PBS
Embedding medium: paraffin or LR White resin
Blocking solution: 5% BSA, 0.1% Tween-20 in PBS
Fluorescent secondary antibody
DAPI for nuclear counterstaining
Anti-fading mounting medium
Tissue preparation:
Fix freshly harvested tissue in 4% paraformaldehyde for 4 hours at room temperature
Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)
Embed in paraffin or LR White resin
Section to 5-10 μm thickness using a microtome
Immunostaining procedure:
Deparaffinize and rehydrate sections
Perform antigen retrieval:
Heat-induced: 10 mM sodium citrate buffer (pH 6.0) at 95°C for 10 minutes
Enzymatic: 0.01% trypsin in PBS at 37°C for 10 minutes
Block in 5% BSA solution for 1 hour at room temperature
Incubate with primary At5g39180 antibody (1:100-1:500 dilution) overnight at 4°C
Wash 3× with PBS + 0.1% Tween-20
Incubate with fluorescent secondary antibody (1:500) for 1-2 hours at room temperature
Wash 3× with PBS + 0.1% Tween-20
Counterstain with DAPI (1 μg/mL) for 5 minutes
Mount in anti-fade medium and seal
Critical controls:
Primary antibody omission
Pre-immune serum control
Peptide competition assay
Tissue from At5g39180 knockout plants
This protocol is optimized based on successful immunolocalization of similar germin-like proteins in plant tissues, with attention to the secreted nature of At5g39180, which may require careful fixation to preserve extracellular localization .
Common Issues and Solutions for At5g39180 Western Blotting:
| Issue | Potential Causes | Solutions |
|---|---|---|
| No signal | - Insufficient protein loading - Antibody dilution too high - Protein degradation | - Increase protein amount (15-30 μg) - Use 1:1000 antibody dilution - Add protease inhibitors fresh to extraction buffer |
| Multiple bands | - Cross-reactivity with homologous proteins - Protein degradation - Post-translational modifications | - Use peptide competition assay - Include reducing agents in sample buffer - Compare pattern with predicted modifications |
| High background | - Insufficient blocking - Secondary antibody concentration too high - Membrane overexposure | - Increase blocking time (overnight at 4°C) - Reduce secondary antibody (1:10,000) - Use PVDF membrane and TBST for washes |
Recommended Protocol Modifications:
Extraction buffer optimization:
Include 10 mM dithiothreitol to maintain reducing conditions
Add 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail
For phosphorylation studies, include phosphatase inhibitors (Na₃VO₄, NaF)
Sample preparation:
Heat samples at 70°C for 5 minutes instead of 95°C to prevent aggregation
Load 15-20 μg total protein per lane for typical detection
Transfer optimization:
Use wet transfer at 30V overnight at 4°C for efficient transfer of germin-like proteins
Verify transfer efficiency with reversible staining (Ponceau S)
These recommendations are based on protocols that have successfully detected similar germin-like proteins in plant extracts .
To rigorously distinguish between true At5g39180 signal and non-specific binding, implement the following comprehensive validation approach:
1. Genetic validation controls:
Test the antibody on tissues from:
At5g39180 T-DNA insertion mutants (should show no signal)
At5g39180 CRISPR knockout lines (should show no signal)
At5g39180 overexpression lines (should show enhanced signal)
Wild-type plants (baseline signal)
2. Peptide competition assay:
Pre-incubate the antibody with:
Specific peptide used as immunogen (should block specific signal)
Unrelated control peptide (should not affect specific signal)
Compare signal intensity between blocked and unblocked antibody
3. Orthogonal method validation:
Correlate protein detection with mRNA levels using qRT-PCR
Compare results with GFP-tagged At5g39180 detection using anti-GFP antibodies
Validate using mass spectrometry to confirm protein identity in bands recognized by the antibody
4. Cross-reactivity assessment:
Test antibody against recombinant proteins from related germin-like protein family members
Create a dot blot array with synthetic peptides representing similar epitopes from related proteins
5. Independent epitope approach:
Use two antibodies raised against different epitopes of At5g39180
True signal should be detected by both antibodies at the same molecular weight and location
This systematic approach is based on established antibody validation principles and provides multiple lines of evidence to differentiate specific from non-specific signals .
For maximum preservation of At5g39180 antibody functionality, implement these storage and handling protocols based on best practices for similar plant protein antibodies:
Storage conditions:
Long-term storage:
Store lyophilized antibody at -20°C in original sealed container
Avoid freeze-thaw cycles by storing in smaller aliquots once reconstituted
Expected stability: 1+ year for lyophilized form; 6 months for reconstituted form
Working solution storage:
Store at 4°C for up to 2 weeks with preservative (0.02% sodium azide)
For longer storage, add 50% glycerol and keep at -20°C
Reconstitution protocol:
Briefly centrifuge the vial before opening to collect material at the bottom
Reconstitute in 50 μl sterile water for a typical concentration
Allow to stand at room temperature for 10 minutes
Gently mix by inversion and brief vortexing (avoid excessive foaming)
Make smaller working aliquots (e.g., 10 μl) to avoid repeated freeze-thaw cycles
Document reconstitution date and conditions
Stability considerations:
Avoid repeated freeze-thaw cycles (limit to ≤5)
Monitor antibody performance over time using positive controls
For experiments requiring maximum sensitivity, use freshly thawed aliquots
These recommendations align with standard protocols for polyclonal antibodies against plant proteins like At5g39180, ensuring maximum retention of specificity and sensitivity over time .
Advanced computational approaches can significantly enhance At5g39180 antibody design through several innovative strategies:
1. Epitope prediction and optimization:
Implement machine learning algorithms to identify antigenic regions specific to At5g39180
Use protein structure prediction tools (e.g., AlphaFold) to visualize epitope accessibility
Apply molecular dynamics simulations to assess epitope flexibility and solvent exposure
2. Direct energy-based preference optimization:
Leverage conditional diffusion models to jointly model antibody sequences and structures
Apply residue-level decomposed energy preference to guide generation of antibodies with rational structures
Implement gradient surgery to address conflicts between various types of energy (attraction vs. repulsion)
3. Antibody-antigen binding simulation:
Use molecular docking to predict binding modes between candidate antibodies and At5g39180
Calculate binding energies to rank antibody candidates
Perform in silico mutagenesis to optimize binding interface residues
4. Cross-reactivity prediction:
Apply sequence and structural alignment tools to identify potentially cross-reactive proteins
Calculate similarity scores between epitopes of At5g39180 and other germin-like proteins
Design computational filters to exclude antibody candidates with potential cross-reactivity
Research has demonstrated that generative AI approaches can achieve binding rates of 10.6% for heavy chain CDR3 designs in zero-shot antibody design efforts , suggesting similar approaches could be applied to develop highly specific At5g39180 antibodies with reduced experimental screening requirements.
At5g39180 antibodies are becoming valuable tools in advanced plant-pathogen interaction studies through several innovative applications:
1. Spatiotemporal mapping of defense responses:
Monitor At5g39180 protein localization before and after pathogen infection
Track protein redistribution during immune responses using immunofluorescence microscopy
Correlate protein accumulation with infection progression in different tissue types
2. Identification of post-translational modifications:
Develop modification-specific antibodies (phospho-, glyco-, ubiquitin-specific)
Map PTM changes during infection using Western blot analysis
Correlate modifications with protein activity and interaction patterns
3. Proximity-dependent labeling:
Use antibody-enzyme conjugates (e.g., APEX, BioID) to identify proteins in close proximity to At5g39180 during immune responses
Map the dynamic interactome changes upon pathogen challenge
Identify novel components of immunity pathways
4. MAPK activation monitoring:
Develop assays linking At5g39180 to MAPK cascade activation
Compare phosphorylation patterns with standardized immune elicitation assays
Examine activation in response to flg22 and elf18 treatments (100 nM for 5 min)
5. Integration with split-root experiments:
Use At5g39180 antibodies to study systemic acquired resistance signaling
Monitor protein abundance in infected versus uninfected portions of split-root systems
These approaches are particularly valuable for understanding how germin-like proteins like At5g39180 contribute to PAMP-triggered immunity and interact with BAK1-dependent defense signaling pathways.
At5g39180 antibodies can be leveraged for comprehensive mapping of protein-protein interactions in plant immune networks through these advanced methodologies:
1. Co-immunoprecipitation coupled with mass spectrometry:
Use At5g39180 antibodies to pull down the protein and its interacting partners
Analyze protein complexes by LC-MS/MS to identify novel interactors
Compare interactome composition before and after immune elicitation
Validate key interactions using reciprocal co-IP and BiFC
2. Proximity-dependent labeling:
Generate fusion proteins combining At5g39180 with BioID or APEX2
Use antibodies to immunoprecipitate At5g39180 complexes after biotin labeling
Identify labeled proteins that exist in close proximity (within ~10 nm)
Map spatial organization of At5g39180 within defense-related protein complexes
3. In situ protein-protein interaction analysis:
Apply proximity ligation assay (PLA) using At5g39180 antibodies with antibodies against candidate interactors
Visualize interaction events as fluorescent dots in fixed cells/tissues
Quantify changes in interaction frequency during immune responses
4. Integrative network analysis:
Combine antibody-based interaction data with transcriptomic data
Correlate At5g39180 expression patterns with interacting partners
Map into known defense signaling pathways (e.g., BAK1-mediated PTI signaling)
Implementation example: Based on research showing At5g39180 is down-regulated in BAK1(Y610F) plants , investigators could use At5g39180 antibodies to test for direct interaction with BAK1 or downstream MAPK components, potentially revealing how this germin-like protein contributes to PAMP-triggered immunity signaling cascades.
To ensure experimental reproducibility with At5g39180 antibodies, implement this comprehensive quality control framework:
1. Standardized validation panel for each batch:
| Test | Acceptance Criteria | Method |
|---|---|---|
| Specificity | Single band at expected MW in wild-type; absent in knockout | Western blot |
| Sensitivity | Detection limit ≤50 ng recombinant protein | Dilution series |
| Reproducibility | CV <15% between technical replicates | Multiple blots |
| Cross-reactivity | No detection of homologous proteins | Dot blot array |
| Lot-to-lot variation | Signal difference <20% between lots | Side-by-side testing |
2. Reference standard development:
Create a stable positive control (e.g., recombinant At5g39180)
Establish a standard curve for each antibody batch
Document batch-specific optimal working dilutions
3. Application-specific validation:
For Western blot: Test linearity across protein concentration range
For immunoprecipitation: Verify % recovery of spiked protein
For immunolocalization: Confirm reproducible staining patterns
4. Stability monitoring program:
Test antibody performance at defined intervals (0, 3, 6, 12 months)
Document any sensitivity loss over time
Establish maximum shelf-life based on performance metrics
5. Documentation requirements: